Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Sunday, August 21, 2016

The Genentech Medical Affairs team is trying to recruit PPMS patients and their support partners for an advisory board this fall (2016)


                                                                  
  

Click here to receive MS news via e-mail




AD (advisory) BOARD RECRUITMENT INFO

A pharmaceutical/biotech company is in the process of developing a new potential multiple sclerosis (MS) therapy and will be hosting a small Patient/Care-partner Advisory Board meeting on Thursday, November 3, 2016 in Chicago, IL.

At this one-day meeting, people with a diagnosis of primary progressive multiple sclerosis (PPMS) and their Support partners will be invited to share their experiences and challenges living with PPMS. This advice will inform the pharmaceutical/biotech company’s work in providing information about the product and appropriately engaging with the MS community.

The pharmaceutical/biotech company will reimburse the travel expenses of invited participants, and provide an honorarium as thanks for their time and participation. 

Participants must:
  • be between the ages of 18 and 55
  • have a diagnosis (made by a physician) of PPMS for 3 to 10 years
  • not currently be participating in an MS drug clinical trial
  • be interested in participating, with or without a care-partner; and
  • be willing and able to travel to Chicago, IL, for a one-day meeting on Thursday, November 3rd.  The meeting will be held at a hotel near the Chicago O’Hare International Airport. 
If you are interested in attending, please contact Sam Wunderle at Stem Scientific by email or phone.
201-271-6160

No comments: